1 | european society for clinical | | | | | | | 9 | 1.17% |
2 | society for clinical neuropharmacology | | | | | | | 5 | 0.65% |
3 | the european society for | | | | | | | 4 | 0.52% |
4 | of the european society | | | | | | | 4 | 0.52% |
5 | for clinical neuropharmacology dates | | | | | | | 4 | 0.52% |
6 | meeting was held in | | | | | | | 3 | 0.39% |
7 | european workshop on clinical | | | | | | | 3 | 0.39% |
8 | meeting of the european | | | | | | | 3 | 0.39% |
9 | 1983 in vienna it | | | | | | | 2 | 0.26% |
10 | in vienna it was | | | | | | | 2 | 0.26% |
11 | aims of the society | | | | | | | 2 | 0.26% |
12 | was held in march | | | | | | | 2 | 0.26% |
13 | and the presidency was | | | | | | | 2 | 0.26% |
14 | first meeting was held | | | | | | | 2 | 0.26% |
15 | the first meeting was | | | | | | | 2 | 0.26% |
16 | clinical neuropharmacology congress dates | | | | | | | 2 | 0.26% |
17 | shared by w birkmayer | | | | | | | 2 | 0.26% |
18 | by w birkmayer and | | | | | | | 2 | 0.26% |
19 | of the society the | | | | | | | 2 | 0.26% |
20 | vienna it was called | | | | | | | 2 | 0.26% |
21 | meeting of the association | | | | | | | 2 | 0.26% |
22 | official journal of the | | | | | | | 2 | 0.26% |
23 | to further the development | | | | | | | 1 | 0.13% |
24 | place in vienna innsbruck | | | | | | | 1 | 0.13% |
25 | in vienna innsbruck budapest | | | | | | | 1 | 0.13% |
26 | vienna innsbruck budapest rome | | | | | | | 1 | 0.13% |
27 | society this goal has | | | | | | | 1 | 0.13% |
28 | innsbruck budapest rome pamplona | | | | | | | 1 | 0.13% |
29 | european society this goal | | | | | | | 1 | 0.13% |
30 | budapest rome pamplona bratislava | | | | | | | 1 | 0.13% |
31 | rome pamplona bratislava brussels | | | | | | | 1 | 0.13% |
32 | a european society this | | | | | | | 1 | 0.13% |
33 | belgrade and groningen from | | | | | | | 1 | 0.13% |
34 | and groningen from the | | | | | | | 1 | 0.13% |
35 | from the association to | | | | | | | 1 | 0.13% |
36 | groningen from the association | | | | | | | 1 | 0.13% |
37 | further the development of | | | | | | | 1 | 0.13% |
38 | the association to the | | | | | | | 1 | 0.13% |
39 | association to the society | | | | | | | 1 | 0.13% |
40 | to the society therefore | | | | | | | 1 | 0.13% |